Search: onr:"swepub:oai:DiVA.org:uu-417229" >
Mebendazole is uniq...
-
Andersson, ClaesUppsala universitet,Cancerfarmakologi och beräkningsmedicin
(author)
Mebendazole is unique among tubulin-active drugs in activating the MEK-ERK pathway
- Article/chapterEnglish2020
Publisher, publication year, extent ...
-
2020-08-04
-
Springer Science and Business Media LLC,2020
-
electronicrdacarrier
Numbers
-
LIBRIS-ID:oai:DiVA.org:uu-417229
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-417229URI
-
https://doi.org/10.1038/s41598-020-68986-0DOI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
We recently showed that the anti-helminthic compound mebendazole (MBZ) has immunomodulating activity in monocyte/macrophage models and induces ERK signalling. In the present study we investigated whether MBZ induced ERK activation is shared by other tubulin binding agents (TBAs) and if it is observable also in other human cell types. Curated gene signatures for a panel of TBAs in the LINCS Connectivity Map (CMap) database showed a unique strong negative correlation of MBZ with MEK/ERK inhibitors indicating ERK activation also in non-haematological cell lines. L1000 gene expression signatures for MBZ treated THP-1 monocytes also connected negatively to MEK inhibitors. MEK/ERK phosphoprotein activity testing of a number of TBAs showed that only MBZ increased the activity in both THP-1 monocytes and PMA differentiated macrophages. Distal effects on ERK phosphorylation of the substrate P90RSK and release of IL1B followed the same pattern. The effect of MBZ on MEK/ERK phosphorylation was inhibited by RAF/MEK/ERK inhibitors in THP-1 models, CD3/IL2 stimulated PBMCs and a MAPK reporter HEK-293 cell line. MBZ was also shown to increase ERK activity in CD4+ T-cells from lupus patients with known defective ERK signalling. Given these mechanistic features MBZ is suggested suitable for treatment of diseases characterized by defective ERK signalling, notably difficult to treat autoimmune diseases.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Selvin, ToveUppsala universitet,Cancerfarmakologi och beräkningsmedicin(Swepub:uu)tovse668
(author)
-
Blom, KristinUppsala universitet,Cancerfarmakologi och beräkningsmedicin(Swepub:uu)kribl842
(author)
-
Rubin, JennyUppsala universitet,Cancerfarmakologi och beräkningsmedicin(Swepub:uu)jeeri172
(author)
-
Berglund, MalinUppsala universitet,Cancerfarmakologi och beräkningsmedicin(Swepub:uu)malbe920
(author)
-
Jarvius, MalinUppsala universitet,Cancerfarmakologi och beräkningsmedicin(Swepub:uu)maemi734
(author)
-
Lenhammar, LenaUppsala universitet,Cancerfarmakologi och beräkningsmedicin(Swepub:uu)lenalenh
(author)
-
Parrow, VendelaUppsala universitet,Cancerfarmakologi och beräkningsmedicin(Swepub:uu)venpa974
(author)
-
Loskog, Angelica S.,1973-Uppsala universitet,Klinisk immunologi(Swepub:uu)angelosk
(author)
-
Fryknäs, MårtenUppsala universitet,Cancerfarmakologi och beräkningsmedicin(Swepub:uu)mafry516
(author)
-
Nygren, PeterUppsala universitet,Experimentell och klinisk onkologi(Swepub:uu)peterng
(author)
-
Larsson, RolfUppsala universitet,Cancerfarmakologi och beräkningsmedicin(Swepub:uu)rolflars
(author)
-
Uppsala universitetCancerfarmakologi och beräkningsmedicin
(creator_code:org_t)
Related titles
-
In:Scientific Reports: Springer Science and Business Media LLC10:12045-2322
Internet link
Find in a library
To the university's database
- By the author/editor
-
Andersson, Claes
-
Selvin, Tove
-
Blom, Kristin
-
Rubin, Jenny
-
Berglund, Malin
-
Jarvius, Malin
-
show more...
-
Lenhammar, Lena
-
Parrow, Vendela
-
Loskog, Angelica ...
-
Fryknäs, Mårten
-
Nygren, Peter
-
Larsson, Rolf
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Basic Medicine
-
and Pharmacology and ...
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Cancer and Oncol ...
- Articles in the publication
-
Scientific Repor ...
- By the university
-
Uppsala University